These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30143564)

  • 1.
    Dickson DW; Heckman MG; Murray ME; Soto AI; Walton RL; Diehl NN; van Gerpen JA; Uitti RJ; Wszolek ZK; Ertekin-Taner N; Knopman DS; Petersen RC; Graff-Radford NR; Boeve BF; Bu G; Ferman TJ; Ross OA
    Neurology; 2018 Sep; 91(12):e1182-e1195. PubMed ID: 30143564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
    Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
    Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
    Wider C; Ross OA; Nishioka K; Heckman MG; Vilariño-Güell C; Jasinska-Myga B; Erketin-Taner N; Rademakers R; Graff-Radford NR; Mash DC; Papapetropoulos S; Duara R; Uchikado H; Wszolek ZK; Farrer MJ; Dickson DW
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):424-9. PubMed ID: 22291217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of GBA variants in Lewy body disease neuropathology.
    Walton RL; Koga S; Beasley AI; White LJ; Griesacker T; Murray ME; Kasanuki K; Hou X; Fiesel FC; Springer W; Uitti RJ; Fields JA; Botha H; Ramanan VK; Kantarci K; Lowe VJ; Jack CR; Ertekin-Taner N; Savica R; Graff-Radford J; Petersen RC; Parisi JE; Reichard RR; Graff-Radford NR; Ferman TJ; Boeve BF; Wszolek ZK; Dickson DW; Ross OA; Heckman MG
    Acta Neuropathol; 2024 Mar; 147(1):54. PubMed ID: 38472443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE-ε4 and BIN1 increase risk of Alzheimer's disease pathology but not specifically of Lewy body pathology.
    Talyansky S; Le Guen Y; Kasireddy N; Belloy ME; Greicius MD
    Acta Neuropathol Commun; 2023 Sep; 11(1):149. PubMed ID: 37700353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of APOE in atypical parkinsonism syndromes.
    Sabir MS; Blauwendraat C; Ahmed S; Serrano GE; Beach TG; Perkins M; Rice AC; Masliah E; Morris CM; Pihlstrom L; Pantelyat A; Resnick SM; Cookson MR; Hernandez DG; Albert M; Dawson TM; Rosenthal LS; Houlden H; Pletnikova O; Troncoso J; Scholz SW
    Neurobiol Dis; 2019 Jul; 127():142-146. PubMed ID: 30798004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.
    Uchikado H; Lin WL; DeLucia MW; Dickson DW
    J Neuropathol Exp Neurol; 2006 Jul; 65(7):685-97. PubMed ID: 16825955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE DNA methylation is altered in Lewy body dementia.
    Tulloch J; Leong L; Chen S; Keene CD; Millard SP; Shutes-David A; Lopez OL; Kofler J; Kaye JA; Woltjer R; Nelson PT; Neltner JH; Jicha GA; Galasko D; Masliah E; Leverenz JB; Yu CE; Tsuang D
    Alzheimers Dement; 2018 Jul; 14(7):889-894. PubMed ID: 29544979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.
    Ferman TJ; Arvanitakis Z; Fujishiro H; Duara R; Parfitt F; Purdy M; Waters C; Barker W; Graff-Radford NR; Dickson DW
    Parkinsonism Relat Disord; 2013 Feb; 19(2):227-31. PubMed ID: 23182311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies.
    Koo KYG; Schweizer TA; Fischer CE; Munoz DG
    Curr Alzheimer Res; 2019; 16(3):243-250. PubMed ID: 30605058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
    Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
    Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
    Jin Y; Li F; Sonoustoun B; Kondru NC; Martens YA; Qiao W; Heckman MG; Ikezu TC; Li Z; Burgess JD; Amerna D; O'Leary J; DeTure MA; Zhao J; McLean PJ; Dickson DW; Ross OA; Bu G; Zhao N
    Acta Neuropathol; 2022 Jun; 143(6):641-662. PubMed ID: 35471463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.
    Jellinger KA
    J Neural Transm (Vienna); 2021 May; 128(5):687-699. PubMed ID: 33928445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease.
    Koga S; Li F; Zhao N; Roemer SF; Ferman TJ; Wernick AI; Walton RL; Faroqi AH; Graff-Radford NR; Cheshire WP; Ross OA; Dickson DW
    Brain Pathol; 2020 Jul; 30(4):766-778. PubMed ID: 32232888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia.
    Gan J; Chen Z; Liu S; Shi Z; Liu Y; Wang XD; Liu C; Ji Y
    BMC Neurol; 2022 Sep; 22(1):355. PubMed ID: 36123648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.
    Tsuang DW; Wilson RK; Lopez OL; Luedecking-Zimmer EK; Leverenz JB; DeKosky ST; Kamboh MI; Hamilton RL
    Neurology; 2005 Feb; 64(3):509-13. PubMed ID: 15699383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.